Welcome to the International AIDS Society-USA Core Faculty

Research Topics

Metabolic complications of HIV
Lipodystrophy
HIV and hepatitis C virus coinfection

Lecture and Writing Topics

Lipodystrophy, metabolic complications of HIV
Adverse effects of antiretroviral therapy
Cardiovascular complications of HIV
Clinical trials methodology

Current Professional Summary

Dr Glesby is an Associate Professor of Medicine and Public Health at Weill Medical College of Cornell University and Co-Director of the Cornell Clinical Trials Unit. He is also the Regional Clinical Director of the New York-New Jersey AIDS Education and Training Center.

Committees and Organizations

Member, Hepatitis Committee, Adult ACTG
Member, Optimization of Co-Infection and Co-Morbidity Management Committee, Adult ACTG
Member, Infectious Diseases Society of America
Member, American College of Physicians
Member, Cases on the Web Editorial Board, International AIDS Society-USA

Honors and Awards

Delta Omega Public Health Honor Society (1997)
Helen B. Taussig Research Prize, Young Investigators Day, Johns Hopkins University School of Medicine (1996)
Phi Beta Kappa (1989)
Alpha Omega Alpha Medical Honor Society (1989)
John E. Carey Young Investigator Award, Adult AIDS Clinical Trials Group (2003)

Education

McGill University, BSc, Biochemistry (1985)
Johns Hopkins University School of Medicine, MD (1989)
Johns Hopkins Hospital, Residency in Internal Medicine (1989–1992)
Johns Hopkins Hospital, Fellow in Infectious Diseases (1992–1996)
Johns Hopkins University School of Hygiene and Public Health, PhD in Clinical Investigation (1997)

Selected Publications

Glesby MJ, Hoover DR, Vaamonde CM. Osteonecrosis in patients infected with human immunodeficiency virus infection: a case-control study. J Infect Dis. 2001;184:519-523.
Dube MP, Stein JH, Aberg JA, Fichtenbaum CJ, Gerber JG, Tashima KT, Henry WK, Currier JS, Sprecher D, Glesby MJ, for the Adult AIDS Clinical Trials Group Cardiovascular Subcommittee. Guidelines for the evaluation and management of dyslipidemia in HIV-infected adults receiving antiretroviral therapy. Recommendations of the HIV Medical Association of the Infectious Diseases Society of America and the Adult AIDS Clinical Trials Group. Clin Infect Dis. 2003;37:613-627.
Yoon C, Gulick RM, Hoover DR, Vaamonde CM, Glesby MJ. Case-control study of diabetes mellitus in HIV-infected patients. J Acquir Immune Defic Syndr. 2004;37:1464-1469.
Glesby MJ, Hoover DR, Tan T, Shi Q, Gao W, French AL, Maurer T, Young M, DeHovitz J, Ru J, Anastos K. Herpes zoster in women with and at risk for human immunodeficiency virus infection: data from the Women’s Interagency HIV Study. J Acquir Immune Defic Syndr. 2004;37:1604-1609.
Glesby MJ, Bassett R, Alston B, Fichtenbaum C, Jacobson EL, Owens S, Race E, Sherman K for the ACTG A5088 team. Pilot study of low dose interleukin-2, pegylated interferon-alfa2b, and ribavirin for the treatment of hepatitis C virus infection in patients with human immunodeficiency virus infection. J Infect Dis. 2005;191:686-693.
Glesby MJ, Aberg JA, Kendall MA, Fichtenbaum CJ, Hafner R, Hall S, Grosskopf N, Zolopa AR, Gerber JG, for the Adult AIDS Clinical Trials Group A5159 Protocol Team. Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockers. Clin Pharmacol Ther. 2005;78:143-153.
Marks KM, Petrovic LM, Talal AH, Murray MP, Gulick RM, Glesby MJ. Histologic findings and clinical characteristics associated with hepatic steatosis in HIV/HCV coinfected patients. J Infect Dis. 2005;192:1943-1949.
Vaamonde CM, Hoover DR, Anastos K, Tan T, Shi Q, Gao W, Kovacs A, Cohen M, DeHovitz J, Glesby MJ. Factors associated with poor immunologic response to virologic suppression by highly active antiretroviral therapy in HIV-infected women. AIDS Res Hum Retroviruses. 2006;22:222-231.